热门资讯> 正文
InspireMD通过合并融资筹集5800万美元;股价上涨
2025-07-31 20:46
- InspireMD (NASDAQ:NSPR) raised ~$58M through a PIPE financing and warrant exercises.
- The $40.1M PIPE was led by OrbiMed and Marshall Wace, with participation from board members and other investors.
- 16.56M shares and pre-funded warrants were sold at $2.42/share.
- An additional $17.9M was raised from warrant exercises triggered by FDA PMA approval of CGuard Prime.
- Funds will support U.S. market launch, commercial expansion, and general corporate use.
- InspireMD plans to file a registration statement to enable resale of securities from the PIPE.
- The PIPE closing is expected by August 1, 2025.
- NSPR shares up 7.6% premarket on Thursday.
- Source: Press release
More on InspireMD
- InspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript
- InspireMD outlines Q3 2025 FDA approval target for CGuard Prime
- Seeking Alpha’s Quant Rating on InspireMD
- Historical earnings data for InspireMD
- Financial information for InspireMD
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
